Regulation

Regulation  958 CMR 12.00: Drug pricing review

Date: 03/06/2020
Organization: Massachusetts Health Policy Commission
Regulatory Authority: MGL c. 6D, § 8A
MGL c. 118E, § 12A
Official Version: Purchase the official print version

958 CMR 12.00 specifies the procedures by which the Commission may review information relative to a Referred Manufacturer's pricing practices and determine whether its pricing of a Drug is unreasonable or excessive in relation to the Drug's value.

Download a PDF copy of the regulation below.

Table of Contents

Help Us Improve Mass.gov  with your feedback

Please do not include personal or contact information.
Feedback